Decreased expression of interleukin-37 in the ectopic and eutopic endometria of patients with adenomyosis.

about

Decreased expression of interleukin-37 in the ectopic and eutopic endometria of patients with adenomyosis.

Item

http://www.wikidata.org/entity/Q48004919

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Decreased expression of interl ...... of patients with adenomyosis.

@en

Decreased expression of interl ...... of patients with adenomyosis.

@nl

type

Item

label

Decreased expression of interl ...... of patients with adenomyosis.

@en

Decreased expression of interl ...... of patients with adenomyosis.

@nl

prefLabel

Decreased expression of interl ...... of patients with adenomyosis.

@en

Decreased expression of interl ...... of patients with adenomyosis.

@nl

P1476

Decreased expression of interl ...... of patients with adenomyosis.

@en

P2093

Jian Fa Jiang

http://www.w3.org/2001/XMLSchema#string

Min Xue

http://www.w3.org/2001/XMLSchema#string

Song Shu Xiao

http://www.w3.org/2001/XMLSchema#string

P2860

Eutopic endometrial interleukin-18 system mRNA and protein expression at the level of endometrial-myometrial interface in adenomyosis patients

IL-37 is a fundamental inhibitor of innate immunity

Plasma levels of IL-37 and correlation with TNF-α, IL-17A, and disease activity during DMARD treatment of rheumatoid arthritis

Annotating genes with potential roles in the immune system: six new members of the IL-1 family

The Impact of Adenomyosis on Women's Fertility.

Interleukin-37 mediates the antitumor activity in hepatocellular carcinoma: role for CD57+ NK cells.

Structural and molecular features of the endomyometrium in endometriosis and adenomyosis.

Suppression of innate inflammation and immunity by interleukin-37.

Role of caspase-1 in nuclear translocation of IL-37, release of the cytokine, and IL-37 inhibition of innate immune responses.

An update on the pharmacological management of adenomyosis.

P304

83-86

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/09513590.2017.1354367

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28762845

http://www.w3.org/2001/XMLSchema#string